The post Nvidia Unveils Its New RTX Spark Chip For Windows Laptops And Desktops appeared on BitcoinEthereumNews.com. Topline Nvidia on Monday unveiled its new RTXThe post Nvidia Unveils Its New RTX Spark Chip For Windows Laptops And Desktops appeared on BitcoinEthereumNews.com. Topline Nvidia on Monday unveiled its new RTX

Nvidia Unveils Its New RTX Spark Chip For Windows Laptops And Desktops

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Topline

Nvidia on Monday unveiled its new RTX Spark chip for consumer Windows laptops and desktops, which it touted as being capable of running “personal AI agents,” marking the company’s first foray into making a fully integrated consumer chip as it looks to take on the likes of Intel, AMD, Apple and Qualcomm.

Nvidia CEO Jensen Huang introduces the RTX Spark laptop during his keynote speech at Computex 2026 in Taipei.

AFP via Getty Images

Key Facts

The RTX Spark is a cut-down version of the chips Nvidia uses on its AI supercomputers and the company claims it will be able to run powerful local AI agents, along with popular games and productivity software like Adobe’s Photoshop.

Nvidia has been making consumer laptops and desktop GPUs for decades, but unlike the RTX Spark—which uses the AI giant’s own custom-made CPU—those computers had to be paired with either an Intel or AMD CPU.

The announcement was made during Nvidia CEO Jensen Huang’s keynote at the Computex trade show in Taiwan, where he boasted that the chipmaker and Microsoft are collaborating to “reinvent the PC.”

Huang showed off RTX Spark laptops on stage, running the latest James Bond video game “007 First Light” and the racing game “Forza Horizon 6,” followed by a Mac Mini-sized desktop also powered by the same chip.

The company did not announce a specific launch date for these new computers, but said they will be available “this fall” and be made by multiple PC manufacturers like ASUS, Dell, HP, Lenovo, Microsoft and MSI.

No pricing details were shared either, but a senior company official told the Wall Street Journal that they will be “ priced at the premium end of the market.”

Crucial Quote

“Today, when you think about your phone, the one thing you don’t do with it is make phone calls. You do just about everything else. So that phone means something very different to you, than a phone of the past. I’m certain what’s going to happen here is that the PC 10 years from now and PC you think about today…is going to be completely different,” Huang said in his keynote. He then added: “I could totally imagine that some day there’s actually an AI supercomputer in your house,” as he compared it to commonplace appliances people have today including lawnmowers and dishwashers.

This is a developing story.

Source: https://www.forbes.com/sites/siladityaray/2026/06/01/nvidia-shows-off-first-windows-laptops-and-desktops-powered-entirely-by-its-own-chip/

Market Opportunity
RateX Logo
RateX Price(RTX)
$1.168
$1.168$1.168
-0.59%
USD
RateX (RTX) Live Price Chart

SPACEX(PRE) Launchpad

SPACEX(PRE) LaunchpadSPACEX(PRE) Launchpad

Register for a chance to win a free lucky draw

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Bitcoin shorts risk $2.5 billion liquidation at $72K: Are bears in danger?

Bitcoin shorts risk $2.5 billion liquidation at $72K: Are bears in danger?

Bitcoin is poised for a reversal if ETF demand returns or a ceasefire occurs, potentially crushing short sellers in a massive price squeeze.
Share
Coin Telegraph2026/04/04 19:58
Robotics Automation Prototyping: Engineering Kinetic Agility into End-Effectors

Robotics Automation Prototyping: Engineering Kinetic Agility into End-Effectors

Inertia is the invisible tax on modern industrial throughput. Every millisecond a robotic arm spends decelerating, or waiting for high-frequency vibrations to settle
Share
Techbullion2026/04/02 18:25

RealStocks Now Live

RealStocks Now LiveRealStocks Now Live

Trade real U.S. stock via regulated brokerage